Related Experiment Video
Updated: Jun 8, 2026

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases
Published on: March 1, 2024
Advances in Diagnosis-Pulmonology
Emily Stone1, Xinxin Hu2, Jane Sandra Afriyie-Mensah3
1Department of Thoracic Medicine and Lung Transplantation, St Vincent's Hospital, Sydney, Australia; University of New South Wales, Sydney, Australia; Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia; NHMRC CuRE Centre of Research Excellence to Prevent and Detect Curable Lung Cancer, Brisbane, Australia.
Pulmonologists have advanced lung cancer care through improved screening, minimally invasive diagnostics, and targeted therapies. These key developments enhance early detection, treatment, and patient outcomes in lung cancer management.
Area of Science:
- Pulmonary Medicine
- Oncology
- Diagnostic Imaging
Background:
- Pulmonologists have significantly advanced lung cancer detection, diagnosis, and management over the last 20 years.
- Understanding of lung cancer epidemiology and risk factors has improved global screening programs.
- Advances in bronchoscopy and endoluminal treatments enable minimally invasive diagnostic and therapeutic approaches.
Purpose of the Study:
- To review major developments in pulmonary diagnostics for lung cancer over the past two decades.
- To explore the clinical impact of these advancements on patient care and outcomes.
- To discuss future research and innovation potential in lung cancer diagnostics and treatment.
Main Methods:
- Review of major developments in pulmonary diagnostics and lung cancer care.
- Expert panel discussion on technological and clinical advancements.
- Analysis of the impact of innovations on diagnosis, staging, and treatment.
Main Results:
- Refinements in bronchoscopy facilitate minimally invasive diagnosis and staging.
- Technological advances enable potential one-step diagnosis-staging-treatment for early-stage lung cancer.
- Biomarker discovery aids in risk stratification, targeted therapy selection, and recurrence prediction.
Conclusions:
- Pulmonary diagnostics have transformed lung cancer care, improving clinical outcomes.
- A multidisciplinary team approach is crucial for high-quality, evidence-based lung cancer management.
- Ongoing research and innovation promise further advancements in lung cancer diagnostics and therapeutics.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Pneumonia III: Complications and Assessment
Chronic Obstructive Pulmonary Disease-I: Introduction
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: